Stroke Research Initiative to Advance Equity (STRIVE)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06075719 |
Recruitment Status :
Not yet recruiting
First Posted : October 10, 2023
Last Update Posted : October 10, 2023
|
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date | October 4, 2023 | ||||
First Posted Date | October 10, 2023 | ||||
Last Update Posted Date | October 10, 2023 | ||||
Estimated Study Start Date | October 2023 | ||||
Estimated Primary Completion Date | October 2028 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures |
Patient-Centered Outcome Measures [ Time Frame: 5 years ] Assess patient-centered outcomes (PCOs) amongst stroke survivors and their caregivers in the MedStar Health System longitudinally.
Stroke Impact Scale and the Modified Caregiver Strain Index
|
||||
Original Primary Outcome Measures | Same as current | ||||
Change History | No Changes Posted | ||||
Current Secondary Outcome Measures |
|
||||
Original Secondary Outcome Measures | Same as current | ||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title | Stroke Research Initiative to Advance Equity | ||||
Official Title | Stroke Research Initiative to Advance Equity | ||||
Brief Summary |
2.2 Hypothesis: We hypothesize that stroke survivors that come from historically marginalized populations, specifically African American and Latinos, will have lower patient-centered outcome scores overall as compared to their Caucasian counterparts. In addition, we hypothesize that the difference PCO scores between Caucasian and African American and Latino populations will be due in part to experienced discrimination and not SDoH alone. . |
||||
Detailed Description | Not Provided | ||||
Study Type | Observational | ||||
Study Design | Observational Model: Cohort Time Perspective: Prospective |
||||
Target Follow-Up Duration | Not Provided | ||||
Biospecimen | Not Provided | ||||
Sampling Method | Non-Probability Sample | ||||
Study Population | Stroke Survivors from the MedStar Health System and their Caregivers. | ||||
Condition | Stroke | ||||
Intervention | Not Provided | ||||
Study Groups/Cohorts |
|
||||
Publications * | Not Provided | ||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status | Not yet recruiting | ||||
Estimated Enrollment |
1000 | ||||
Original Estimated Enrollment | Same as current | ||||
Estimated Study Completion Date | October 2029 | ||||
Estimated Primary Completion Date | October 2028 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria | Stroke Survivor: Inclusion Criteria: ≥ 18 years old Acute Ischemic Stroke (AIS) or Intracerebral Hemorrhage (ICH) patients that have been cared for in the MedStar Healthcare system AIS of ICH in the last six weeks Ability to communicate in English, Spanish, Amharic, Mandarin Chinese or French (most common languages in the greater Washington, DC area) Exclusion Criteria: Transient Ischemic Attack (TIA) or Subarachnoid Hemorrhage (SAH) Unable to complete required forms Life expectancy less than 6 months Caregiver Inclusion Criteria Age ≥ 18 Self-identify as primary caregiver for the stroke survivor Ability to communicate in English, Spanish, Amharic, Mandarin Chinese, French Exclusion Criteria Unable to complete study survey forms Life expectancy less than 6 months |
||||
Sex/Gender |
|
||||
Ages | 18 Years and older (Adult, Older Adult) | ||||
Accepts Healthy Volunteers | No | ||||
Contacts | |||||
Listed Location Countries | Not Provided | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number | NCT06075719 | ||||
Other Study ID Numbers | STUDY00006503 | ||||
Has Data Monitoring Committee | No | ||||
U.S. FDA-regulated Product |
|
||||
IPD Sharing Statement | Not Provided | ||||
Current Responsible Party | M. Carter Denny, Medstar Health Research Institute | ||||
Original Responsible Party | Same as current | ||||
Current Study Sponsor | Medstar Health Research Institute | ||||
Original Study Sponsor | Same as current | ||||
Collaborators | Not Provided | ||||
Investigators | Not Provided | ||||
PRS Account | Medstar Health Research Institute | ||||
Verification Date | October 2023 |